Kinnate Biopharma Inc (KNTE) Directors and Executive Officers - CSIMarket
CSIMarket
 
Kinnate Biopharma Inc   (NASDAQ: KNTE)

Kinnate Biopharma Inc

Officers & Directors


1. Nima Farzan - CEO: Mr. Farzan was previously the CEO of PaxVax, a vaccine manufacturer, and prior to that, he worked at Genentech Inc. for 13 years.

2. Heather Rowe - COO: Ms. Rowe was previously the COO of eFFECTOR Therapeutics, a biotech company, and prior to that, she worked at biotech companies such as Amylin Pharmaceuticals and Applied Molecular Evolution.

3. Matthew L. Recknor - CFO: Mr. Recknor was previously the CEO and CFO of Tragara Pharmaceuticals, and prior to that, he worked at Gilead Sciences Inc.

4. Donald Peet - CSO: Dr. Peet was previously the CSO at Deciphera Pharmaceuticals, and prior to that, he worked at biotech companies such as Exelixis and Tularik Inc.

5. Karen Akinsanya - CMO: Dr. Akinsanya was previously the CMO at CytomX Therapeutics, and prior to that, she worked at biotech companies such as Genentech Inc. and Merck & Co., Inc.

Again, note that this information may be outdated and the profile may have since been updated.

Kinnate Biopharma Inc currently has 99 employees.






KNTE Management Effectiveness KNTE Revenue per Employee KNTE Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.